FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lipofen (fenofibrate) filed by ANI Pharmaceuticals, Inc., marking a regulatory action on this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• LIPOFEN (FENOFIBRATE)

Snippet

SUPPL AP for LIPOFEN (FENOFIBRATE)